Stay updated with breaking news from Sofinnova Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
14 Dec 2023 - Mission gains clearance from US FDA for Phase II trial of MTX652 after it receives official approval of its Investigational New Drug application ...
Experienced team of serial entrepreneurs and investors will partner with leading academic institutions to identify the most innovative ideas and create the biotech champions of tomorrowPARIS--(BUSINESS WIRE)--#VC--Sofinnova Partners (“Sofinnova"), a leading European life sciences venture capital firm based in Paris,...
COPENHAGEN, Denmark--(BUSINESS WIRE)--Dec 12, 2023--
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
/PRNewswire/ -- Mission Therapeutics ("Mission" or the "Company"), a clinical-stage biotech developing first-in-class therapeutics targeting mitophagy, today...